Stay updated on Atezolizumab with BCG in NMIBC Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.

Latest updates to the Atezolizumab with BCG in NMIBC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision label updated from v3.4.1 to v3.4.2; no substantive changes to the study content are visible.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision tag updated to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check27 days agoChange DetectedAdded a glossary display and updated metadata to show 'Last Update Submitted that Met QC Criteria' and Revision: v3.4.0, while removing the previous 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. The update does not modify any study details, eligibility criteria, endpoints, or enrollment.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a consolidated Locations section listing study sites in CA, IL, MD, NY, NC, OH, OK, and OR. Per-state location blocks were removed, and the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.9%

- Check91 days agoChange DetectedAdded a note indicating that publications are automatically filled from PubMed and may not be about the study; updated the page revision to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab with BCG in NMIBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab with BCG in NMIBC Clinical Trial page.